Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Grows By 250.0%

BioSyent Inc. (OTCMKTS:BIOYF) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 1,400 shares, a growth of 250.0% from the November 15th total of 400 shares. Based on an average daily trading volume, of 8,200 shares, the days-to-cover ratio is presently 0.2 days.

BioSyent Stock Down 1.0 %

Shares of BioSyent stock traded down $0.08 on Wednesday, hitting $8.05. The company had a trading volume of 251 shares, compared to its average volume of 2,252. BioSyent has a twelve month low of $5.93 and a twelve month high of $8.90. The stock has a 50-day moving average of $8.01 and a 200-day moving average of $7.64.

BioSyent Cuts Dividend

The business also recently declared a dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be issued a $0.0322 dividend. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, November 29th.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.